Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Velan Capital Investment Management LP - 26 Feb 2026 SCHEDULE 13D/A Report for Edesa Biotech, Inc. Common Shares, without par value (EDSA)
- Filing manager
- Velan Capital Investment Management LP
- Reporting owner
- Velan Capital Investment Management LP
- Beneficially owned shares
- 834,700 shares
- Large-stake signal
-
Ownership
10%Beneficial ownership of this reported class.
Shares
834,700 sharesShares beneficially owned as disclosed.
Event date
26 Feb 2026Date tied to the ownership event or amendment.
Accepted by SEC
02 Mar 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 10%
- Symbol
- EDSA
- Shares outstanding
- 8,355,355 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 02 Mar 2026, 19:03:40 UTC
- Event date
- 26 Feb 2026
- Prior SEC filing
- 18 Feb 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Velan Capital Investment Management LP disclosed 10% ownership in Edesa Biotech, Inc. Common Shares, without par value (EDSA) on 26 Feb 2026.
Key facts
- Velan Capital Investment Management LP filed SCHEDULE 13D/A for Edesa Biotech, Inc. Common Shares, without par value (EDSA).
- Disclosed ownership: 10%.
- Date of event: 26 Feb 2026.
Change
- Previous schedule filing date: 18 Feb 2025.
- Current filing was accepted on 02 Mar 2026, 19:03.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (9)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Velan Capital Master Fund LP | 6.8% | 569,075 | 0 | 569,075 | /s/ Adam Morgan | Adam Morgan, Managing Member of Velan Capital Holdings LLC, its General Partner | 0001964356 |
| Velan Horizon Fund LP | 0.2% | 15,625 | 0 | 15,625 | /s/ Adam Morgan | Adam Morgan, Managing Member of Velan Horizon GP LLC, its General Partner | 0002057740 |
| Velan Capital Opportunity Fund II LLC | 3% | 250,000 | 0 | 250,000 | /s/ Adam Morgan | Adam Morgan, Managing Member of Velan Capital Holdings LLC, its Managing Member | 0002057744 |
| Velan Horizon GP LLC | 0.2% | 15,625 | 0 | 15,625 | /s/ Adam Morgan | Adam Morgan, Managing Member | 0002057821 |
| Velan Capital Holdings LLC | 9.8% | 819,075 | 0 | 819,075 | /s/ Adam Morgan | Adam Morgan, Managing Member | 0001964353 |
| Velan Capital Investment Management LP | 10% | 834,700 | 0 | 834,700 | /s/ Adam Morgan | Adam Morgan, Managing Member of Velan Capital Management LLC, its General Partner | 0001848809 |
| Velan Capital Management LLC | 10% | 834,700 | 0 | 834,700 | /s/ Adam Morgan | Adam Morgan, Managing Member | 0001964355 |
| Morgan Adam | 10% | 834,700 | 0 | 834,700 | /s/ Adam Morgan | Adam Morgan | 0001964335 |
| VENKATARAMAN BALAJI | 10% | 834,700 | 0 | 834,700 | /s/ Balaji Venkataraman | Balaji Venkataraman | 0001114916 |
CIK / CUSIP context first